Home/Filings/4/0000950170-24-002516
4//SEC Filing

LEONARD JOHN M 4

Accession 0000950170-24-002516

CIK 0001652130other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 4:51 PM ET

Size

5.7 KB

Accession

0000950170-24-002516

Insider Transaction Report

Form 4
Period: 2024-01-03
LEONARD JOHN M
DirectorPresident and CEO
Transactions
  • Sale

    Common Stock

    2024-01-03$29.46/sh19,223$566,310846,486 total
Holdings
  • Common Stock

    (indirect: By Trust)
    58,415
Footnotes (2)
  • [F1]Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2024, and does not represent a volitional trade by the Reporting Person.
  • [F2]Shares held by the John M. Leonard 2015 Irrevocable Trust.

Documents

1 file

Issuer

Intellia Therapeutics, Inc.

CIK 0001652130

Entity typeother

Related Parties

1
  • filerCIK 0001563584

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:51 PM ET
Size
5.7 KB